InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: rawman post# 70206

Monday, 04/13/2020 12:06:46 PM

Monday, April 13, 2020 12:06:46 PM

Post# of 97081
Not really true. I recommend the Supplemental Disclosure document as further reading for those who want to know more about how this came about and what the test kit plans were based on. (Start reading on page 15 of this document:Supplemental Disclosures

Here is a quote from that document (and remember this document was posted March 30th, so it doesn't include the recent information given in PRs since then)

A few days later we received three cites from The Bio regarding technical papers written in the last five years where the researchers and scientists discussed in those white papers the ability to use a method called impedance to identify and classify certain (now familiar) classes of virus. All three papers described their methodologies in detail and included sample data sets. In all three cases the researchers designed and built a bench level chemistry methodology and their version of an identification device, and then performed tests on live patients. In all cases the number of patients (subjects) tested was statistically significant. The importance of these publications indicated that a testing device and chemistry method, using impedance (better described as an energy pulse with traits somewhat similar to an electric current and a radio wave pulse), could be created in short order to measure the presence or absence of such a virus (of interest) such as influenza and H1N1 influenza, and of course SARS and Covid-19. The company’s GenUltimate TBG product makes use of impedance technology to measure the number of red blood cells in a patient blood sample, information relevant to a glucose measurement in that same patient. Mr. Berman, the company’s CEO, became convinced that a similarly configured device could be built for the determination of Covid-19.



Keep reading for what they have done since then. They expect a minimum 95% accuracy rate and believe it will be 97%-98% accurate.

And they are basing their plan on the platform they have already developed and extensively tested for their other FDA products on the market. This isn't a whole new field for them in other words.

Does anyone hold that their current glucose testing strips don't work or are not accurate?